New York State Common Retirement Fund
ATOS icon

New York State Common Retirement Fund’s Atossa Therapeutics ATOS Stock Holding History

New York State Common Retirement Fund’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,053
Closed -$10.6K – 3210
2025
Q1 		$10.6K Hold
1,053
– – ﹤0.01% 3076
2024
Q4 		$14.9K Hold
1,053
– – ﹤0.01% 3085
2024
Q3 		$24K Sell
1,053
-4,800
-82% -$96.9K ﹤0.01% 3020
2024
Q2 		$104K Buy
+5,853
New +$129K ﹤0.01% 2750
2022
Q3 		– Sell
-62
Closed -$1K – 3276
2022
Q2 		$1K Sell
62
-3,607
-98% -$56.8K ﹤0.01% 3319
2022
Q1 		$69K Hold
3,669
– – ﹤0.01% 3095
2021
Q4 		$88K Sell
3,669
-19
-0.5% -$695 ﹤0.01% 3110
2021
Q3 		$180K Sell
3,688
-2,992
-45% -$174K ﹤0.01% 2942
2021
Q2 		$633K Buy
+6,680
New +$354K ﹤0.01% 2472

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

New York State Common Retirement Fund's ATOS Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 1,053 shares — an estimated $10.6K sold.

New York State Common Retirement Fund first reported a position in ATOS in Q2 2021 and held it in 9 quarters. The position peaked at $633K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,053 Atossa Therapeutics shares in Q2 2025, an estimated $10.6K.
  • New York State Common Retirement Fund first reported a position in Atossa Therapeutics in Q2 2021 and held it in 9 quarters.
  • New York State Common Retirement Fund's Atossa Therapeutics position peaked at $633K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.